Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer

Journal of Gynecologic Oncology

Volumn 20, Issue 2, 2009, Pages 101-106

  Bae, Jaeman ^a   Myong, Cheol Lim ^b   Choi, Jae Ho ^b   Song, Yong Joong ^b   Lee, Kyoung Soo ^b   Kang, Sokbom ^b   Seo, Sang Soo ^b   Park, Sang Yoon ^b  

^a Konkuk University Hospital   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Prognostic factor; Recurrent ovarian cancer; Secondary cytoreductive surgery

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CARBOPLATIN; CISPLATIN; NAVELBINE; PACLITAXEL; TOPOTECAN;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER SURVIVAL; CELLULITIS; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOREDUCTIVE SURGERY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OVARY CANCER; OVERALL SURVIVAL; PANCREAS DISEASE; PANCREAS JUICE; PELVIS TUMOR; PLEURA EFFUSION; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RECTUM FISTULA; RECURRENT CANCER; UNIVARIATE ANALYSIS; URETER FISTULA; URETEROVAGINAL FISTULA; VAGINA DISEASE; WOUND DEHISCENCE;

EID: 77953263003     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2009.20.2.101     Document Type: Article

References (20)

1. Burke TW, Morris M. Secondary cytoreductive surgery for ovarian cancer. Obstet Gynecol Clin North Am 1994; 21: 167-178 (Pubitemid 24100782)
2. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975; 42: 101-104
3. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002; 20: 1248-1259 (Pubitemid 34177431)
4. Chen LM, Karlan BY. Recurrent ovarian carcinoma: is there a place for surgery? Semin Surg Oncol 2000; 19: 62-68
5. Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000; 88: 144-153 (Pubitemid 30027690)
6. Ayhan A, Gultekin M, Taskiran C, Aksan G, Celik NY, Dursun P, et al. The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience. Am J Obstet Gynecol 2006; 194: 49-56. (Pubitemid 43017774)
7. Berek JS, Hacker NF, Lagasse LD, Nieberg RK, Elashoff RM. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 1983; 61: 189-193
8. Segna RA, Dottino PR, Mandeli JP, Konsker K, Cohen CJ. Secondary cytoreduction for ovarian cancer following cisplatin therapy. J Clin Oncol 1993; 11: 434-439 (Pubitemid 23071038)
9. Zang RY, Zhang ZY, Li ZT, Chen J, Tang MQ, Liu Q, et al. Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J Surg Oncol 2000; 75: 24-30. (Pubitemid 32059841)
10. Munkarah A, Levenback C, Wolf JK, Bodurka-Bevers D, Tortolero-Luna G, Morris RT, et al. Secondary cytoreductive surgery for localized intra-abdominal récurrences in epithelial ovarian cancer. Gynecol Oncol 2001; 81: 237-241 (Pubitemid 32424168)
11. Scarabelli C, Gallo A, Carbone A. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 2001; 83: 504-512 (Pubitemid 33139711)
12. Tay EH, Grant PT, Gebski V, Hacker NF. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet Gynecol 2002; 99: 1008-1013 (Pubitemid 34621223)
13. Zang RY, Li ZT, Tang J, Cheng X, Cai SM, Zhang ZY, et al. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? Cancer 2004; 100: 1152-1161
14. Onda T, Yoshikawa H, Yasugi T, Yamada M, Matsumoto K, Taketani Y. Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection. Br J Cancer 2005; 92: 1026-1032 (Pubitemid 40546664)
15. Gungor M, Ortac F, Arvas M, Kosebay D, Sonmezer M, Kose K. The role of secondary cytoreductive surgery for recurrent ovarian cancer. Gynecol Oncol 2005; 97: 74-79 (Pubitemid 40403677)
16. Gronlund B, Lundvall L, Christensen IJ, Knudsen JB, Hogdall C. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum. Eur J Surg Oncol 2005; 31: 67-73. (Pubitemid 40103927)
17. Chi DS, McCaughty K, Diaz JP, Huh J, Schwabenbauer S, Hummer AJ, et al. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 2006; 106: 1933-1939 (Pubitemid 43673208)
18. Tebes SJ, Sayer RA, Palmer JM, Tebes CC, Martino MA, Hoffman MS. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 2007; 106: 482-487 (Pubitemid 47302452)
19. Munkarah AR, Coleman RL. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer. Gynecol Oncol 2004; 95: 273-280 (Pubitemid 39445861)
20. Salani R, Santillan A, Zahurak ML, Giuntoli RL 2nd, Gardner GJ, Armstrong DK, et al. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Cancer 2007; 109: 685-691